Root Financial Partners
ACAD icon

Root Financial Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Root Financial Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.01K Buy
+447
New +$12K ﹤0.01% 1966
2026
Q2 		– Sell
-289
Closed -$6.43K – 425
2026
Q1 		$6.43K Sell
289
-43
-13% -$1.03K ﹤0.01% 1855
2025
Q4 		$8.87K Buy
332
+69
+26% +$1.65K ﹤0.01% 1551
2025
Q3 		$5.61K Buy
+263
New +$6.22K ﹤0.01% 1681

Other funds holding ACAD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Root Financial Partners's ACAD Position: Q3 2026 in Review

Root Financial Partners opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 447 shares worth $9.01K. The stake represents ﹤0.01% of the portfolio and ranks #1966 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ACAD as recently as Q1 2026.

Root Financial Partners first reported a position in ACAD in Q3 2025 and has held it in 4 quarters since. 263 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Root Financial Partners held 447 shares of Acadia Pharmaceuticals worth $9.01K as of Q3 2026.
  • Acadia Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1966 holding.
  • Root Financial Partners first reported a position in Acadia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 263 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.